IP Verse

Mrna Therapy For Argininosuccinate Synthetase Deficiency - EP3060303

The patent EP3060303 was granted to Shire Human Genetic Therapies on Nov 14, 2018. The application was originally filed on Oct 22, 2014 under application number EP14799919A. The patent is currently recorded with a legal status of "Revoked".

EP3060303

SHIRE HUMAN GENETIC THERAPIES
Application Number
EP14799919A
Filing Date
Oct 22, 2014
Status
Revoked
Sep 3, 2021
Grant Date
Nov 14, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

WITHERS & ROGERSAug 14, 2019GRAF VON STOSCHADMISSIBLE

Patent Citations (38) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS4373071
DESCRIPTIONUS4401796
DESCRIPTIONUS4415732
DESCRIPTIONUS4458066
DESCRIPTIONUS4500707
DESCRIPTIONUS4668777
DESCRIPTIONUS4737323
DESCRIPTIONUS4897355
DESCRIPTIONUS4973679
DESCRIPTIONUS5047524
DESCRIPTIONUS5132418
DESCRIPTIONUS5153319
DESCRIPTIONUS5171678
DESCRIPTIONUS5262530
DESCRIPTIONUS5334761
DESCRIPTIONUS5700642
DESCRIPTIONUS5744335
DESCRIPTIONUS5885613
DESCRIPTIONUS8093367
DESCRIPTIONUS8304529
DESCRIPTIONWO2005121348
DESCRIPTIONWO2010042877
DESCRIPTIONWO2010053572
DESCRIPTIONWO2011068810
DESCRIPTIONWO2012170889
DESCRIPTIONWO2012170930
DESCRIPTIONWO2013063468
INTERNATIONAL-SEARCH-REPORTWO2011068810
INTERNATIONAL-SEARCH-REPORTWO2012075040
INTERNATIONAL-SEARCH-REPORTWO2012170889
INTERNATIONAL-SEARCH-REPORTWO2013063468
INTERNATIONAL-SEARCH-REPORTWO2013149140
INTERNATIONAL-SEARCH-REPORTWO2013185069
INTERNATIONAL-SEARCH-REPORTWO2014144196
OPPOSITIONUS2013259924
OPPOSITIONWO2011068810
OPPOSITIONWO2012170889
OPPOSITIONWO2013151666

Non-Patent Literature (NPL) Citations (5) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- KUHN et al., "mRNA as a Versatile Tool for Exogenous Protein Expression", Current Gene Therapy, (20120000), vol. 12, pages 347 - 361, XP008159357-
OPPOSITION- TAK W., Mak, The Gene Knockout Facts Book, (19980000), vol. I-
OPPOSITION- GROTE et al., "- JCAT: A NOVEL TOOL TO ADAPT CODON USAGE OF A TARGET GENE TO ITS POTENTIAL EXPRESSION HOST", Nucleic Acids Research, (20050701), vol. 33, no. 2, pages W526 - W531, XP009081066
OPPOSITION- WELCH et al., "You're one in a googol: optimizing genes for protein expression", J. R. Soc. Interface (2009, (20090311), vol. 6, pages S467 - S476, XP055019124
OPPOSITION- FATH et al., "Multiparameter RNA and Codon Optimization: A Standardized Tool to Assess and Enhance Autologous Mammalian Gene Expression", PLOS ONE, (20110303), vol. 6, no. 3, XP055531212

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents